165 related articles for article (PubMed ID: 18465314)
21. Chitosan as an active support for assembly of metal nanoparticles and application of the resultant bioconjugates in catalysis.
Wei D; Ye Y; Jia X; Yuan C; Qian W
Carbohydr Res; 2010 Jan; 345(1):74-81. PubMed ID: 19932470
[TBL] [Abstract][Full Text] [Related]
22. N-hexanoyl chitosan-stabilized magnetic nanoparticles: enhancement of adenoviral-mediated gene expression both in vitro and in vivo.
Bhattarai SR; Kim SY; Jang KY; Lee KC; Yi HK; Lee DY; Kim HY; Hwang PH
Nanomedicine; 2008 Jun; 4(2):146-54. PubMed ID: 18374634
[TBL] [Abstract][Full Text] [Related]
23. Highly active and stable DNAzyme-carbon nanotube hybrids.
Yim TJ; Liu J; Lu Y; Kane RS; Dordick JS
J Am Chem Soc; 2005 Sep; 127(35):12200-1. PubMed ID: 16131179
[TBL] [Abstract][Full Text] [Related]
24. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
[TBL] [Abstract][Full Text] [Related]
25. Biocompatible nanoparticles trigger rapid bacteria clustering.
Larsen MU; Seward M; Tripathi A; Shapley NC
Biotechnol Prog; 2009; 25(4):1094-102. PubMed ID: 19565661
[TBL] [Abstract][Full Text] [Related]
26. C-jun: pharmaceutical target for DNAzyme therapy of multiple pathologies.
Dass CR; Choong PF
Pharmazie; 2008 Jun; 63(6):411-4. PubMed ID: 18604982
[TBL] [Abstract][Full Text] [Related]
27. Nanobiotechnology: protein-nanomaterial interactions.
Kane RS; Stroock AD
Biotechnol Prog; 2007; 23(2):316-9. PubMed ID: 17335286
[TBL] [Abstract][Full Text] [Related]
28. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors.
Bilensoy E; Sarisozen C; Esendağli G; Doğan AL; Aktaş Y; Sen M; Mungan NA
Int J Pharm; 2009 Apr; 371(1-2):170-6. PubMed ID: 19135514
[TBL] [Abstract][Full Text] [Related]
29. Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering.
Yilgor P; Tuzlakoglu K; Reis RL; Hasirci N; Hasirci V
Biomaterials; 2009 Jul; 30(21):3551-9. PubMed ID: 19361857
[TBL] [Abstract][Full Text] [Related]
30. Carboxymethyl chitosan as a matrix material for platinum, gold, and silver nanoparticles.
Laudenslager MJ; Schiffman JD; Schauer CL
Biomacromolecules; 2008 Oct; 9(10):2682-5. PubMed ID: 18816099
[TBL] [Abstract][Full Text] [Related]
31. Potential applications of chitosan in veterinary medicine.
Senel S; McClure SJ
Adv Drug Deliv Rev; 2004 Jun; 56(10):1467-80. PubMed ID: 15191793
[TBL] [Abstract][Full Text] [Related]
32. [Biofabrication with chitosan and its application progress].
Meng F; Zhang A
Sheng Wu Gong Cheng Xue Bao; 2009 May; 25(5):665-71. PubMed ID: 19670633
[TBL] [Abstract][Full Text] [Related]
33. Functional gene silencing mediated by chitosan/siRNA nanocomplexes.
Ji AM; Su D; Che O; Li WS; Sun L; Zhang ZY; Yang B; Xu F
Nanotechnology; 2009 Oct; 20(40):405103. PubMed ID: 19752491
[TBL] [Abstract][Full Text] [Related]
34. Development of bioactive and biodegradable chitosan-based injectable systems containing bioactive glass nanoparticles.
Couto DS; Hong Z; Mano JF
Acta Biomater; 2009 Jan; 5(1):115-23. PubMed ID: 18835230
[TBL] [Abstract][Full Text] [Related]
35. Preparation and characterization of biocompatible chitosan nanoparticles for targeted brain delivery of peptides.
Caban S; Capan Y; Couvreur P; Dalkara T
Methods Mol Biol; 2012; 846():321-32. PubMed ID: 22367822
[TBL] [Abstract][Full Text] [Related]
36. Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor.
Yang R; Shim WS; Cui FD; Cheng G; Han X; Jin QR; Kim DD; Chung SJ; Shim CK
Int J Pharm; 2009 Apr; 371(1-2):142-7. PubMed ID: 19118614
[TBL] [Abstract][Full Text] [Related]
37. A chitosan-dipotassium orthophosphate hydrogel for the delivery of Doxorubicin in the treatment of osteosarcoma.
Ta HT; Dass CR; Larson I; Choong PF; Dunstan DE
Biomaterials; 2009 Jul; 30(21):3605-13. PubMed ID: 19345993
[TBL] [Abstract][Full Text] [Related]
38. Review paper: chitosan derivatives as promising materials for controlled drug delivery.
Prabaharan M
J Biomater Appl; 2008 Jul; 23(1):5-36. PubMed ID: 18593819
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic Potential of DNAzyme Loaded on Chitosan/Cyclodextrin Nanoparticle to Recovery of Chemosensitivity in the MCF-7 Cell Line.
Zokaei E; Badoei-Dalfrad A; Ansari M; Karami Z; Eslaminejad T; Nematollahi-Mahani SN
Appl Biochem Biotechnol; 2019 Mar; 187(3):708-723. PubMed ID: 30039475
[TBL] [Abstract][Full Text] [Related]
40. The synthesis of biocompatible and SERS-active gold nanoparticles using chitosan.
Potara M; Maniu D; Astilean S
Nanotechnology; 2009 Aug; 20(31):315602. PubMed ID: 19597258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
